SCHEMBL21935628

SCHEMBL21935628

CCCC/C=C\C(=O)NC(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB11 A5LHX3 1/20 0.44
PSMA7 O14818 1/20 0.44
PSMB1 P20618 1/20 0.44
PSMA1 P25786 1/20 0.44
PSMA2 P25787 1/20 0.44
PSMA3 P25788 1/20 0.44
PSMA4 P25789 1/20 0.44
PSMB8 P28062 1/20 0.44
PSMB9 P28065 1/20 0.44
PSMA5 P28066 1/20 0.44
PSMB4 P28070 1/20 0.44
PSMB6 P28072 1/20 0.44
PSMB5 P28074 1/20 0.44
PSMB10 P40306 1/20 0.44
PSMB3 P49720 1/20 0.44
PSMB2 P49721 1/20 0.44
PSMA6 P60900 1/20 0.44
PSMA8 Q8TAA3 1/20 0.44
PSMB7 Q99436 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29498993 0.81 PSMB11 (0.45) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL8089108 0.81 PSMB11 (0.45) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL9811553 0.80 PPARG (0.46) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL18322820 0.79 PSMB11 (0.44) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL9776250 0.79 CNR1 (0.46) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL18322819 0.79 PSMB11 (0.44) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL16002541 0.79 PSMB11 (0.44) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL309566 0.78
SCHEMBL5184171 0.78
SCHEMBL230668 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643706-B1 MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES EISAI R&D MAN CO LTD (JP) 2023-11-15 EP disclosed
EP-3643706-A1 MODIFIED NUCLEIC ACID MONOMER COMPOUND AND OLIGONUCLEIC ACID ANALOG Eisai R&D Management Co., Ltd. (JP) 2020-04-29 EP disclosed